-
Je něco špatně v tomto záznamu ?
The NFkB activation domain is 14-amino-acid-long variant of the 9aaTAD
J. Houser, K. Jendruchova, A. Knight, M. Piskacek
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
36825663
DOI
10.1042/bcj20220605
Knihovny.cz E-zdroje
- MeSH
- aktivace transkripce MeSH
- aminokyseliny * metabolismus MeSH
- lidé MeSH
- nádorový supresorový protein p53 * metabolismus MeSH
- NF-kappa B metabolismus MeSH
- sekvence aminokyselin MeSH
- transkripční faktory metabolismus MeSH
- vazba proteinů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The nine-amino-acid transactivation domains (9aaTAD) was identified in numerous transcription factors including Gal4, p53, E2A, MLL, c-Myc, N-Myc, and also in SP, KLF, and SOX families. Most of the 9aaTAD domains interact with the KIX domain of transcription mediators MED15 and CBP to activate transcription. The NFkB activation domain occupied the same position on the KIX domain as the 9aaTADs of MLL, E2A, and p53. Binding of the KIX domain is established by the two-point interaction involving 9aaTAD positions p3-4 and p6-7. The NFkB primary binding region (positions p3-4) is almost identical with MLL and E2A, but secondary NFkB binding region differs by the position and engages the distal NFkB region p10-11. Thus, the NFkB activation domain is five amino acids longer than the other 9aaTADs. The NFkB activation domain includes an additional region, which we called the Omichinski Insert extending activation domain length to 14 amino acids. By deletion, we demonstrated that Omichinski Insert is an entirely non-essential part of NFkB activation domain. In summary, we recognized the NFkB activation domain as prolonged 9aaTAD conserved in evolution from humans to amphibians.
Central European Institute of Technology Masaryk University Brno Brno Czech Republic
Department of Neurosurgery University Hospital Brno Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003592
- 003
- CZ-PrNML
- 005
- 20230425140741.0
- 007
- ta
- 008
- 230418s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1042/BCJ20220605 $2 doi
- 035 __
- $a (PubMed)36825663
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Houser, Josef $u Central European Institute of Technology (CEITEC), Masaryk University Brno, Brno, Czech Republic $u National Centre for Biomolecular Research (NCBR), Faculty of Science, Masaryk University Brno, Brno, Czech Republic $u Core Facility Biomolecular Interactions and Crystallization (CF BIC), Masaryk University Brno, Brno, Czech Republic
- 245 14
- $a The NFkB activation domain is 14-amino-acid-long variant of the 9aaTAD / $c J. Houser, K. Jendruchova, A. Knight, M. Piskacek
- 520 9_
- $a The nine-amino-acid transactivation domains (9aaTAD) was identified in numerous transcription factors including Gal4, p53, E2A, MLL, c-Myc, N-Myc, and also in SP, KLF, and SOX families. Most of the 9aaTAD domains interact with the KIX domain of transcription mediators MED15 and CBP to activate transcription. The NFkB activation domain occupied the same position on the KIX domain as the 9aaTADs of MLL, E2A, and p53. Binding of the KIX domain is established by the two-point interaction involving 9aaTAD positions p3-4 and p6-7. The NFkB primary binding region (positions p3-4) is almost identical with MLL and E2A, but secondary NFkB binding region differs by the position and engages the distal NFkB region p10-11. Thus, the NFkB activation domain is five amino acids longer than the other 9aaTADs. The NFkB activation domain includes an additional region, which we called the Omichinski Insert extending activation domain length to 14 amino acids. By deletion, we demonstrated that Omichinski Insert is an entirely non-essential part of NFkB activation domain. In summary, we recognized the NFkB activation domain as prolonged 9aaTAD conserved in evolution from humans to amphibians.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádorový supresorový protein p53 $x metabolismus $7 D016159
- 650 12
- $a aminokyseliny $x metabolismus $7 D000596
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a aktivace transkripce $7 D015533
- 650 _2
- $a transkripční faktory $x metabolismus $7 D014157
- 650 _2
- $a NF-kappa B $x metabolismus $7 D016328
- 650 _2
- $a vazba proteinů $7 D011485
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jendruchova, Kristina $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Kamenice 5, 625 00 Brno, Czech Republic
- 700 1_
- $a Knight, Andrea $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Kamenice 5, 625 00 Brno, Czech Republic $u Department of Neurosurgery, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Piskacek, Martin $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Kamenice 5, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000262831542
- 773 0_
- $w MED00009308 $t The Biochemical journal $x 1470-8728 $g Roč. 480, č. 5 (2023), s. 297-306
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36825663 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425140737 $b ABA008
- 999 __
- $a ok $b bmc $g 1924338 $s 1189801
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 480 $c 5 $d 297-306 $e 2023May13 $i 1470-8728 $m Biochemical journal (London. 1984) $n Biochem J $x MED00009308
- LZP __
- $a Pubmed-20230418
